A Retrospective Observational Study of Nivolumab in Combination With Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC Patients: Real-World Experience in Taiwan (NEOREAL)
Conditions
- Non Small Cell Lung Cancer NSCLC
Sponsor
Ono Pharmaceutical Co., Ltd.
Collaborators